<DOC>
	<DOCNO>NCT00191035</DOCNO>
	<brief_summary>The purpose study ass efficacy , safety tolerability atomoxetine administer daily treatment adolescent ADHD 8 week 52 week</brief_summary>
	<brief_title>Maintenance Benefit With Atomoxetine Hydrochloride Adolescents With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>Patients must ADHD . Must 1316 year age . Must able swallow capsule . Expected achieve score 70 IQ test Willing reliable keep appts . clinic visit test Treatment within last 30 day drug receive regulatory approval indication . Patients weigh less 40 kg great 70 kg . Patients document history Bipolar I II disorder , psychosis Patients document history autism , asperger 's syndrome pervasive developmental disorder</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>